5IS5
Discovery and Pharmacological Characterization of Novel Quinazoline-based PI3K delta-selective Inhibitors
Summary for 5IS5
Entry DOI | 10.2210/pdb5is5/pdb |
Descriptor | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform, 5-{4-[3-(4-acetylpiperazine-1-carbonyl)phenyl]quinazolin-6-yl}-2-methoxypyridine-3-carbonitrile (3 entities in total) |
Functional Keywords | phosphoinositide 3-kinase, isoform-sepcific inhibitors, transferase |
Biological source | Mus musculus (Mouse) |
Total number of polymer chains | 1 |
Total formula weight | 120491.99 |
Authors | Gutmann, S.,Rummel, G.,Shrestha, B. (deposition date: 2016-03-15, release date: 2016-08-10, Last modification date: 2024-01-10) |
Primary citation | Hoegenauer, K.,Soldermann, N.,Stauffer, F.,Furet, P.,Graveleau, N.,Smith, A.B.,Hebach, C.,Hollingworth, G.J.,Lewis, I.,Gutmann, S.,Rummel, G.,Knapp, M.,Wolf, R.M.,Blanz, J.,Feifel, R.,Burkhart, C.,Zecri, F. Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors. Acs Med.Chem.Lett., 7:762-767, 2016 Cited by PubMed: 27563400DOI: 10.1021/acsmedchemlett.6b00119 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.85 Å) |
Structure validation
Download full validation report